A US pilot lab needed 17 proprietary downstream buffers to keep to its drug substance manufacturing schedule: chromatography buffers, strong acids and bases, concentrated detergents, and alcohol storage solutions, all tested for low endotoxin and filled into 10 L single-use bioprocessing bags. This case study traces the timeline from purchase order to release, showing how accelerated batch record creation, raw material sourcing, and QC testing (including a USP <71> sterility hold) all happened in under four weeks. RUO+ grade delivered GMP-ready quality on an RUO timeline, with raw materials selected for straightforward transfer to GMP manufacturing.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.